ACC 2015 Roundup: CTA no benefit, Abbott's MitraClip, Philips' IntelliSpace

Screening coronary artery disease patients using computed-tomography angiography is no better than functional testing in improving outcomes, according to a large clinical study by the National Heart, Lung & Blood Institute, plus more from the annual meeting of the American College of Cardiology. A large clinical trial comparing computed-tomography angiography with functional testing found no benefit to clinical outcomes with CTA, which also exposes patients to large doses of radiation. American College of Cardiology, Biotronik, Edwards Lifesciences, Keystone Heart, Royal Philips, Abbott LaboratoriesNews Well, Clinical Trials, Cardiovascularread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news